Free Trial

Forte Biosciences (FBRX) Short Interest Ratio & Short Volume

Forte Biosciences logo
$19.34 +0.68 (+3.64%)
(As of 12/20/2024 05:16 PM ET)

Forte Biosciences Short Interest Data

Forte Biosciences (FBRX) has a short interest of 211,200 shares, representing 16.50% of the float (the number of shares available for trading by the public). This marks a 6,111.76% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 141,065 shares to cover all short positions.

Current Short Interest
211,200 shares
Previous Short Interest
3,400 shares
Change Vs. Previous Month
+6,111.76%
Dollar Volume Sold Short
$4.59 million
Short Interest Ratio
0.4 Days to Cover
Last Record Date
November 30, 2024
Outstanding Shares
1,462,000 shares
Float Size
1,280,000 shares
Short Percent of Float
16.50%
Today's Trading Volume
46,181 shares
Average Trading Volume
141,065 shares
Today's Volume Vs. Average
33%
Short Selling Forte Biosciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Forte Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

FBRX Short Interest Over Time

FBRX Days to Cover Over Time

FBRX Percentage of Float Shorted Over Time

Forte Biosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/30/2024211,200 shares $4.59 million +6,111.8%16.5%0.4 $21.71
11/15/20243,400 shares $18,938.00 +240.0%0.3%0 $5.57
10/31/20241,000 shares $4,450.00 -75.6%0.1%0.1 $4.45
10/15/20244,100 shares $18,942.00 +24.2%0.3%0.4 $4.62
9/30/20243,300 shares $18,447.00 -2.9%0.3%0.4 $5.59
9/15/20243,400 shares $24,752.00 -40.4%0.3%0.6 $7.28
8/31/20245,700 shares $45,030.00 -75.6%0.4%1.2 $7.90
8/15/202423,400 shares $7,183.80 +157.1%N/A0.3 $0.31
7/31/20249,100 shares $5,007.73 -22.9%N/A0.5 $0.55
7/15/202411,800 shares $6,596.20 -41.9%N/A0.6 $0.56
6/30/202420,300 shares $10,901.10 +18.7%N/A1 $0.54
6/15/202417,100 shares $9,558.90 +0.6%N/A0.7 $0.56
5/31/202417,000 shares $10,094.60 -32.3%N/A0.7 $0.59
5/15/202425,100 shares $16,064.00 -12.9%N/A1 $0.64
4/30/202428,800 shares $21,052.80 -12.7%N/A1 $0.73
4/15/202433,000 shares $23,430.00 -3.2%N/A1 $0.71
3/31/202434,100 shares $23,740.42 -19.2%N/A1 $0.70
3/15/202442,200 shares $26,164.00 -36.6%N/A1.2 $0.62
2/29/202466,600 shares $45,474.48 -17.2%N/A1.6 $0.68
2/15/202480,400 shares $55,910.16 +62.4%N/A2.1 $0.70
1/31/202449,500 shares $30,199.95 -28.7%N/A1.1 $0.61
1/15/202469,400 shares $51,356.00 -55.4%N/A1.8 $0.74
12/31/2023155,500 shares $127,774.35 +57.1%N/A3.9 $0.82
12/15/202399,000 shares $74,250.00 +40.4%N/A2.5 $0.75
11/30/202370,500 shares $33,417.00 +21.6%N/A1.7 $0.47
11/15/202358,000 shares $22,045.80 +3.2%N/A1.5 $0.38
10/31/202356,200 shares $27,594.20 -2.9%N/A1.8 $0.49
10/15/202357,900 shares $33,020.37 -10.9%N/A0.7 $0.57
9/30/202365,000 shares $43,030.00 -0.8%N/A0.8 $0.66
9/15/202365,500 shares $53,683.80 -1.8%N/A0.8 $0.82
8/31/202366,700 shares $55,367.67 -7.6%N/A0.8 $0.83
8/15/202372,200 shares $59,204.00 +38.3%N/A0.9 $0.82
7/31/202352,200 shares $52,722.00 -7.6%N/A0.7 $1.01
7/15/202356,500 shares $56,500.00 -0.9%N/A1.8 $1.00
6/30/202357,000 shares $59,280.00 +4.8%N/A0.9 $1.04
6/15/202354,400 shares $56,032.00 +0.4%N/A0.9 $1.03
5/31/202354,200 shares $55,284.00 -4.1%N/A0.8 $1.02
5/15/202356,500 shares $61,076.50 -15.7%N/A0.8 $1.08
4/30/202367,000 shares $71,690.00 -42.4%N/A1 $1.07
4/15/2023116,400 shares $125,712.00 +203.9%N/A1.7 $1.08
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

3/31/202338,300 shares $38,683.00 -27.3%N/A0.6 $1.01
3/15/202352,700 shares $51,999.09 -23.0%N/A1.3 $0.99
2/28/202368,400 shares $69,768.00 +0.4%N/A1.7 $1.02
2/15/202368,100 shares $68,100.00 -2.4%N/A1.7 $1.00
1/31/202369,800 shares $69,800.00 +0.7%N/A1.7 $1.00
1/15/202369,300 shares $70,686.00 -39.5%N/A1.7 $1.02
12/30/2022114,500 shares $114,500.00 +36.8%N/A2.8 $1.00
12/15/202283,700 shares $85,374.00 -16.3%N/A2.1 $1.02
11/30/2022100,000 shares $99,480.00 -19.4%N/A1.9 $0.99
11/15/2022124,100 shares $124,100.00 +17.1%N/A1.9 $1.00
10/31/2022106,000 shares $114,480.00 +1.7%N/A1.2 $1.08
10/15/2022104,200 shares $107,326.00 -10.8%N/A0.7 $1.03
9/30/2022116,800 shares $124,976.00 +8.4%N/A0.6 $1.07
9/15/2022107,800 shares $137,984.00 -2.3%N/A0.4 $1.28
8/31/2022110,300 shares $143,390.00 -30.6%N/A0.4 $1.30
8/15/2022159,000 shares $206,700.00 -3.0%N/A0.6 $1.30
7/31/2022163,900 shares $203,236.00 +7.2%1.4%0.6 $1.24
7/15/2022152,900 shares $194,183.00 -29.2%1.2%0.6 $1.27
6/30/2022215,900 shares $280,670.00 -62.1%1.7%1.1 $1.30
6/15/2022569,500 shares $694,790.00 +1.9%4.5%3 $1.22
5/31/2022559,000 shares $737,880.00 +14.1%4.5%3.5 $1.32
5/15/2022490,100 shares $578,318.00 -7.3%4.0%3 $1.18
4/30/2022528,800 shares $608,120.00 +18.5%4.3%3.4 $1.15
4/15/2022446,100 shares $633,462.00 +9.7%3.6%2.7 $1.42
3/31/2022406,800 shares $593,928.00 +14.2%3.3%2.2 $1.46
3/15/2022356,100 shares $498,540.00 -5.1%2.9%1.6 $1.40
2/28/2022375,300 shares $472,878.00 +0.8%3.0%1.2 $1.26
2/15/2022372,500 shares $540,125.00 -61.5%3.0%1.1 $1.45
1/31/2022968,000 shares $1.64 million +8.5%7.8%2.5 $1.69
1/15/2022892,500 shares $1.54 million -1.2%7.2%1.8 $1.72
12/31/2021903,300 shares $1.93 million +107.0%7.3%1.6 $2.14
12/15/2021436,400 shares $881,528.00 -30.5%3.5%0.6 $2.02
11/30/2021627,800 shares $1.67 million -12.7%5.1%0.5 $2.66
11/15/2021719,200 shares $2.39 million -35.8%5.9%0.3 $3.33
10/29/20211,120,000 shares $3.04 million -6.7%9.6%0.5 $2.71
10/15/20211,200,000 shares $3.34 million -17.8%10.2%0.5 $2.78
9/30/20211,460,000 shares $4.32 million -46.7%12.5%0.7 $2.96
9/15/20212,740,000 shares $9.56 million +67.1%23.4%1.4 $3.49
8/31/20211,640,000 shares $48.25 million -4.7%16.1%1.1 $29.42
8/13/20211,720,000 shares $43.60 million +1.8%16.9%7.6 $25.35
7/30/20211,690,000 shares $50.63 million +20.7%17.3%8.4 $29.96
7/15/20211,400,000 shares $43.13 million +10.2%14.3%7.6 $30.81
6/30/20211,270,000 shares $42.70 million +38.5%13.0%7.3 $33.62
6/15/2021916,800 shares $36.52 million +2.5%9.4%4.9 $39.83
5/28/2021894,100 shares $31.78 million -12.3%9.1%4.2 $35.54
5/14/20211,020,000 shares $32.13 million -1.0%10.4%4.6 $31.50
4/30/20211,030,000 shares $37.85 million +32.1%10.5%4.7 $36.75
4/15/2021779,800 shares $28.37 million +27.9%52.3%3.8 $36.38
3/31/2021609,600 shares $19.62 million -6.1%41.2%3.1 $32.18
3/15/2021648,900 shares $19.20 million +109.5%43.8%4.9 $29.59
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

2/26/2021309,800 shares $8.72 million -13.0%20.9%3.5 $28.16
2/12/2021355,900 shares $12.65 million +0.7%24.1%4.7 $35.53
1/29/2021353,300 shares $12.18 million +4.0%23.7%5.4 $34.47
1/15/2021339,700 shares $12.89 million No Change22.8%4.9 $37.95

FBRX Short Interest - Frequently Asked Questions

What is Forte Biosciences' current short interest?

Short interest is the volume of Forte Biosciences shares that have been sold short but have not yet been covered or closed out. As of November 30th, investors have sold 211,200 shares of FBRX short. 16.50% of Forte Biosciences' shares are currently sold short. Learn More on Forte Biosciences' current short interest.

What is a good short interest percentage for Forte Biosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 16.50% of Forte Biosciences' floating shares are currently sold short.

Is Forte Biosciences' short interest increasing or decreasing?

Forte Biosciences saw a increase in short interest during the month of November. As of November 30th, there was short interest totaling 211,200 shares, an increase of 6,111.8% from the previous total of 3,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Forte Biosciences' float size?

Forte Biosciences currently has issued a total of 1,462,000 shares. Some of Forte Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Forte Biosciences currently has a public float of 1,280,000 shares.

How does Forte Biosciences' short interest compare to its competitors?

16.50% of Forte Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Forte Biosciences: Protara Therapeutics, Inc. (14.64%), Leap Therapeutics, Inc. (4.97%), X4 Pharmaceuticals, Inc. (7.33%), Metagenomi, Inc. (1.45%), Adverum Biotechnologies, Inc. (11.10%), INmune Bio, Inc. (16.73%), Cardiol Therapeutics Inc. (1.46%), Journey Medical Co. (0.76%), Century Therapeutics, Inc. (8.35%), Alto Neuroscience, Inc. (18.59%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks.

What does it mean to sell short Forte Biosciences stock?

Short selling FBRX is an investing strategy that aims to generate trading profit from Forte Biosciences as its price is falling. FBRX shares are trading up $0.68 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Forte Biosciences?

A short squeeze for Forte Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FBRX, which in turn drives the price of the stock up even further.

How often is Forte Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FBRX, twice per month. The most recent reporting period available is November, 30 2024.




This page (NASDAQ:FBRX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners